PRESS RELEASES
Biomedica
Foscama
September 10th, 2002
Biomedica Foscama and Intermune Enter Distribution agreement of Amphocil
™
(Amphotericin B) for the italian market
September 05th, 2001
Biomedica Foscama to distribute Myogen's Perfan™ (Enoximone) in Italy
April 04th, 2001
Further evidence of powerful activity of the new Biomedica Foscama's antioxidant, Raxofelast, in restoring impaired endothelial function and wound healing in diabetes
October 10th, 2000
Advances in parenteral nutrition research and practice presented at 22nd ESPEN Congress
May 22nd, 2000
Bi
omedica Foscama signs co-operation and consultancy agreement with Oxford Nutrition
January 10th, 2000
Biomedica Foscama's leading drug Esafosfina™ acknowledged as a safe and effective phosphorus source in total parenteral nutrition
